Phase 1b trial finds tetravalent E coli bioconjugate vaccine candidate in women with recurrent UTI safe and immunogenic.
Researchers discover a gene variant of MCR-1 from the rectal swab of a leukemic child
May be first case in the United States.
Case presented of patient with extended-spectrum beta-lactamase E. coli infection.
A study has found that the rate of ESBL-E. coli infections increased from 5.28 to 10.5 per 100,000 patients between 2009 and 2014.
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- Are Antibiotic Stewardship Programs the Antidote to Antibiotic Overuse?
- Better Detection and Treatment Needed for H pylori Infections in Children
- FDA Approves New Hepatitis B Vaccine for Adults
- Strategies for Preventing Antibiotic Resistance in Acne
- Oral HPV Prevalence Higher in Men With Concurrent Genital HPV
- Study Finds Burnout Occurs in Over Half of US Surgeons
- HPV Vaccine Linked to Lower Respiratory Papillomatosis Rates
- Novel Antifungal Agent for Treatment of Aspergillus flavus Infections
- Inappropriate Antibiotic Use for Acute Bronchitis Highest in Younger Adults
- ACP, CDC Provides Best Practice Advice on Hepatitis B Management